169 results
SC TO-T
EX-99
Corerx Inc
11 Mar 24
Third party tender offer statement
4:05pm
and less any applicable tax withholding
Pursuant to the Offer to Purchase
Dated March 11, 2024
by
CANE MERGER SUB, INC.,
a wholly owned subsidiary … of $1.10 per Share in cash, without interest and less any applicable tax withholding (such amount or any higher amount per share that may be paid
SC TO-T
EX-99
Corerx Inc
11 Mar 24
Third party tender offer statement
4:05pm
and less any applicable tax withholding
Pursuant to the Offer to Purchase dated March 11, 2024
by
CANE MERGER SUB, INC.
a wholly owned subsidiary … Share in cash, without interest, subject to any applicable tax withholding (the “Offer Price”), upon the terms and subject to the conditions set forth
8-K
EX-10.1
SCTL
Societal CDMO Inc
26 Nov 19
Entry into a Material Definitive Agreement
4:54pm
Exhibit 10.1
TAX MATTERS AGREEMENT
by and between
RECRO PHARMA, INC.
and
BAUDAX BIO, INC.
Dated as of November 20, 2019
TAX MATTERS AGREEMENT …
THIS TAX MATTERS AGREEMENT (this “Agreement”), dated as of November 20, 2019 by and between Recro Pharma, Inc., a Pennsylvania corporation (“Recro
8-K
EX-99.1
SCTL
Societal CDMO Inc
19 Feb 19
Recro Pharma Reports Financial Results for the Fourth Quarter and Year End 2018
7:05am
tax expense for the year ended December 31, 2018 was $17.4 million primarily due to recording of a onetime,non-cash $28.8 million income tax … valuation allowance against our domestic deferred tax assets. The recording of a valuation allowance in the fourth quarter of 2018 was driven by the amendment
8-K
EX-10.1
t3bvnm
13 Aug 21
Vida Strategic Partners Vida Strategic Partners Recro
5:22pm
8-K
ep22f
26 Nov 19
Entry into a Material Definitive Agreement
4:54pm
8-K
EX-10.3
qkjca e7bi7orfhauxwm
19 Dec 14
Departure of Directors or Certain Officers
12:00am
SC TO-I
EX-99
kfl8ysn3u3r278odbc
1 Jun 22
Issuer tender offer statement
5:05pm
SC TO-T
EX-99
e06ao xm4juzuyr
11 Mar 24
Third party tender offer statement
4:05pm